Straumann Holding AG (OTCMKTS:SAUHY) Receives Consensus Recommendation of “Hold” from Brokerages

Straumann Holding AG (OTCMKTS:SAUHY) has received an average rating of “Hold” from the six analysts that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, one has given a buy recommendation and one has assigned a strong buy recommendation to the company.

A number of research analysts have recently issued reports on the stock. UBS Group upgraded shares of Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Citigroup reissued a “sell” rating on shares of Straumann in a research note on Wednesday, January 14th. The Goldman Sachs Group cut shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research report on Monday, October 13th. Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st. Finally, Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Monday, December 15th.

Straumann Price Performance

SAUHY stock opened at $12.24 on Thursday. The business’s fifty day moving average is $11.92 and its 200-day moving average is $11.93. Straumann has a twelve month low of $10.30 and a twelve month high of $15.07.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.